secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aprea Therapeutics, Inc. (APRE)
CIK:        0001781983
Form:       8-K
Filed at:   2025-12-09T23:59:59+00:00
Accession:  0001104659-25-119680
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aprea Therapeutics raises $3.1M in private placement priced at $1.165/unit
--------------------------------------------------------------------------

- Gross proceeds ~$3.1M from 2.62M shares (or pre-funded warrants) and warrants at $1.04 exercise price.
- Combined effective price $1.165 per unit; warrants exercisable for 5 years.
- Net proceeds to extend cash runway into Q1 2027; closing expected December 10, 2025.
- Maxim Group LLC sole placement agent; receives 7% fee and 257,510 placement agent warrants.
- Includes participation from new and existing healthcare investors and insiders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1781983/000110465925119680/0001104659-25-119680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1781983/000110465925119680/tm2533057d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-119680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer